Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 11/20 | 0.50 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.45 |
| ▸ | PGR | P06401 | 3/20 | 0.44 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21131619 | 0.98 | AR (0.54) | ARNR3C1PGRPTPN5ALDH1A1 | |
| SCHEMBL21131795 | 0.97 | AR (0.47) | ARNR3C1PGRPTPN5 | |
| SCHEMBL21131616 | 0.94 | AR (0.51) | ARNR3C1PGRPTPN5 | |
| SCHEMBL21131567 | 0.91 | AR (0.60) | ARNR3C1PGR | |
| SCHEMBL21131796 | 0.91 | AR (0.50) | ARNR3C1PGRPTPN5ESR2 | |
| SCHEMBL21131568 | 0.87 | AR (0.56) | ARNR3C1PGR | |
| SCHEMBL21116477 | 0.87 | AR (0.48) | ARNR3C1PGRPTPN5ESR2 | |
| SCHEMBL21131606 | 0.86 | NR3C1 (0.48) | ARNR3C1ESR2ALDH1A1CYP1A2 | |
| SCHEMBL21131425 | 0.86 | AR (0.40) | ARNR3C1PGR | |
| SCHEMBL21131410 | 0.86 | AR (0.41) | ARNR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11380849-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2022-07-05 | — | — | US | disclosed |
| US-20190198778-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11380849-B2 | Organic molecules for use in optoelectronic devices | OR10J3, NOX3, ORC3 | AR 912/4885NR3C1 323/4885PGR 2416/4885 |
| US-20190198778-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | ORC3, OR10J3, NOX3 | AR 1037/4885NR3C1 316/4885PGR 2672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.